Team Eric Ginsburg, PhD Senior Director, Intellectual Property and Technology Development Senior Director, Intellectual Property and Technology Development
Team Han Sun, PhD Assistant Director, Business Development, The Duckworth Family Cancer Fellow Assistant Director, Business Development, The Duckworth Family Cancer Fellow
Team Benjamin Cox, PhD Senior Manager, Intellectual Property | Medical Device Engineer Senior Manager, Intellectual Property | Medical Device Engineer
Team Mike Hinton, PhD Senior Manager, Business Development and Licensing Senior Manager, Business Development and Licensing
Team Kenneth Gayosa Onishi, PhD Senior Manager, Business Development and Licensing - Microbiome Senior Manager, Business Development and Licensing - Microbiome
Team Shane Thomas Peace, PhD Manager, Intellectual Property and Technology Development Manager, Intellectual Property and Technology Development
Team Anna Wislocki, PhD, MS Senior Associate Director, Accelerators and Investments Senior Associate Director, Accelerators and Investments
News Polsky Commercialization Fellowship Gives PhD Students Dedicated Support to Pursue Entrepreneurship The Polsky Commercialization Fellowship offers PhD students at the University of Chicago the opportunity to create new ventures around promising research and develop leadership skills during a competitive fellowship. “We...
Page Graduate & PhD Students Graduate & PhD Students Transform research into real-world impact through startup accelerators, commercialization resources, interdisciplinary collaboration, and venture-building opportunities across the Polsky innovation ecosystem. *If you are a Chicago Booth...
Team Emily McFadden, PhD Manager, Business Development and Licensing Manager, Business Development and Licensing
News Spotlight on Biopharma Fellowships: AbbVie and Keck Graduate Institute Launch PharmD Fellowship Program
News Onchilles Pharma Advancing Tumor-Killing Drug Candidate to the Clinic University of Chicago spinout Onchilles Pharma plans to initiate first-in-human clinical trials next year for its lead drug candidate – which has demonstrated broad, potent, and direct tumor-killing activity. The...
